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Abstract
Background: One of the most important and often neglected physiological stimuli contributing to the
differentiation of vascular endothelial cells (ECs) into a blood-brain barrier (BBB) phenotype is shear stress (SS). With
the use of a well established humanized dynamic in vitro BBB model and cDNA microarrays, we have profiled the
effect of SS in the induction/suppression of ECs genes and related functions.
Results: Specifically, we found a significant upregulation of tight and adherens junctions proteins and genes.
Trans-endothelial electrical resistance (TEER) and permeability measurements to know substances have shown that
SS promoted the formation of a tight and highly selective BBB. SS also increased the RNA level of multidrug
resistance transporters, ion channels, and several p450 enzymes. The RNA level of a number of specialized carrier-
mediated transport systems (e.g., glucose, monocarboxylic acid, etc.) was also upregulated.
RNA levels of modulatory enzymes of the glycolytic pathway (e.g., lactate dehydrogenase) were downregulated by
SS while those involved in the Krebs cycle (e.g., lactate and other dehydrogenases) were upregulated.
Measurements of glucose consumption versus lactate production showed that SS negatively modulated the
glycolytic bioenergetic pathways of glucose metabolism in favor of the more efficient aerobic respiration. BBB ECs
are responsive to inflammatory stimuli. Our data showed that SS increased the RNA levels of integrins and vascular
adhesion molecules. SS also inhibited endothelial cell cycle via regulation of BTG family proteins encoding genes.
This was paralleled by significant increase in the cytoskeletal protein content while that of membrane, cytosol, and
nuclear sub-cellular fractions decreased. Furthermore, analysis of 2D gel electrophoresis (which allows identifying a
large number of proteins per sample) of EC proteins extracted from membrane sub-cellular endothelial fractions
showed that SS increased the expression levels of tight junction proteins. In addition, regulatory enzymes of the
Krebb’s cycle (aerobic glucose metabolism) were also upregulated. Furthermore, the expression pattern of key
protein regulators of the cell cycle and parallel gene array data supported a cell proliferation inhibitory role for SS.
Conclusions: Genomic and proteomic analyses are currently used to examine BBB function in healthy and
diseased brain and characterize this dynamic interface. In this study we showed that SS plays a key role in
promoting the differentiation of vascular endothelial cells into a truly BBB phenotype. SS affected multiple aspect
of the endothelial physiology spanning from tight junctions formation to cell division as well as the expression of
multidrug resistance transporters. BBB dysfunction has been observed in many neurological diseases, but the
causes are generally unknown. Our study provides essential insights to understand the role played by SS in the
BBB formation and maintenance.
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The blood-brain barrier is a dynamic interface between
the blood and the central nervous system (CNS), that
controls the influx and efflux of biological substances
needed for the brain metabolic processes, as well as for
neuronal function. Therefore the functional and struc-
tural integrity of the BBB is vital to maintain the home-
ostasis of the brain microenvironment.
At the cellular level, the BBB consists of microvascu-
lar endothelial cells (EC) lining the brain microvessels
together with the closely associated astrocytic end-feet
processes [1]. The microcapillary endothelium is char-
acterized by the presence of tight junctions, lack of
fenestrations, and minimal pinocytotic vesicles. In par-
ticular, tight junctions between the cerebral endothelial
cells form a diffusion barrier, which selectively
excludes most blood-borne substances from entering
the brain, protecting it from systemic influences
mediated by substances of all size or polar molecules
such as water soluble compounds (electrolytes). Trans-
port for nutrients (as well as other biologically impor-
tant substances) from the peripheral circulation into
brain parenchyma requires translocation through the
capillary endothelium by specialized carrier-mediated
transport systems. Membrane localization of these
enzymes is indicative of the polarity of the endothelial
functions in the control of the blood-brain interface
[2]. The BBB endothelial cytoplasm is richly endowed
with enzymes, including monoamine oxidase, acid and
alkaline phosphatases, p450 enzymes [3] and is also
characterized by very high density of mitochondria
denoting high metabolic activity [4]. Furthermore, the
cellular membrane hosts a variety of adhesion mole-
cules and integrins that allow for the interaction with
the host immune system when activated by pro-inflam-
matory stimuli [5].
This plethora of highly specialized functions is indica-
tive of a significant level of differentiation that sets apart
the BBB endothelium from that of other vascular beds.
While the physiological environment is certainly respon-
sible for the differentiation of these endothelial cells into
a BBB phenotype, the mechanisms involved are not fully
understood. The surrounding cellular elements (e.g.,
astrocytes) by means of trophic stimuli (some still
unknown) are crucially important for the EC differentia-
tion however, there is an underestimated and poorly
understood mechanical stimuli that also plays a major
role in this process, such as the exposure to shear stress
(SS). SS is a tangential force generated by flow across
the apical surface of vascular endothelium. In this study
we show that SS affects endothelial cell by modulating
the induction/suppression of genes, which impact the
development of BBB properties and functions.
Results
Shear stress promoted BBB tightness
Gene array analysis from EC samples grown under static
and dynamic conditions in presence of abluminal astro-
cytes showed (see Figure 1A) that exposure to capillary-
like SS levels (≅ 6.2 dynes/cm
2) [6,7] increases the RNA
levels of a variety of tight and adherens junction compo-
nents such zonula occludens-1 (ZO-1), Claudin 3 and 5,
cadherins, catenin a2a n db1, and actin a2[ 8 ] .A c t i n
filaments in conjunction with catenin molecules provide
the structural cellular connection with the transmem-
brane proteins forming the inter-endothelial tight and
adherens junctional complexes [9]. The functional sig-
nificance of this response to SS is quite evident if one
looks at the structural integrity and tightness of the cor-
responding vascular endothelial beds. As shown in Fig-
ure 1B EC co-cultured with AH under the influence of
SS formed a significantly more stringent barrier
(TEER≈700 Ohm cm
2) than parallel co-cultures grown
under static condition (TEER≈100 Ohm cm
2). Barrier
selectivity is significantly affected by the tightness of the
vascular bed formed. As shown in Figures 1C and 1D
EC grown under static conditions did not form a viable
barrier capable of differentiating the passage of sub-
stances in relation to their real (in vivo) permeability
distributions. Results from gene array analysis were sup-
ported by comparative protein quantification of tight
and adherens junction proteins in 2D gels of endothelial
protein extracts from membrane sub-cellular fractions
of EC harvested from the co-culture systems. Figure 1E
shows the expression ratio (flow vs. no-flow) of key TJ
components as well as that of adherens junction protein
identified on the 2D gels. Exposure to a physiological
capillary level of SS significantly increased the expres-
sion level of TJ components occludin (2.47 ± SEM
0.147) and claudin 5 (5.91 ± SEM 0.390). The expres-
sion level of the adherens junctions cadherin-1 (2.04 ±
SEM 0.136), -2 (2.00 ± SEM 0.230), -5 (2.13 ± SEM
0.172) were also unregulated. Data were expressed as
fold changes (p < 0.05).
Shear stress induces the endothelial expression of drug
transporters and metabolic properties that allow the BBB
to shield the CNS from potentially harmful substances
Pivotal properties of the BBB are the shielding from
potentially harmful substances and the selective perme-
ability to ions and other nutrients/substances. Exposure
to physiological levels of SS Increased the RNA level of
multidrug resistance transporter (see Figure 2A) com-
monly expressed at the BBB in vivo. These included
ABCB1 (MDR1), ABCC1 (MRP1), ABCC2 (MRP2), and
ABCC5 (MRP5) [10]. Recent studies have also shown
that in addition to multidrug resistance proteins, BBB
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P450 enzymes which may synergistically contribute to
regulate the passage of substances into the brain [3,11].
We now report that exposure to SS increased the
endothelial RNA levels of several CYP450 enzymes (see
Figure 2B). These included members of the CYP1,
CYP2, and CYP3 families (CYP1A1, CYP2B6, CYP2C8,
CYP2J2, CYP3A4, CYP3A5), which are mainly involved
Figure 1 Laminar shear stress promotes tight junction formation. Panel A: Comparison of the level of TJ and adherens junction RNA in EC
grown under dynamic (flow) versus static condition. The tightness of the vascular endothelial bed developed under flow culture condition was
much more stringent than that grown under in the absence of luminal flow. This was demonstrated by the TEER (Panel B) and permeability
measurement to known substances (Panel C). Note also that the BBB established under flow was capable of discriminating the passage of
substances accordingly to their permeability order more efficiently that the BBB established under static condition (Panel D). Gene array findings
were also supported by comparative analysis of TJ and adherens junction proteins identified and quantified (comparative analysis of the
expression levels) on 2D gels of protein extracted from EC membrane sub-cellular fractions (flow and no-flow conditions; Panel E). Note that “*”
refers to a statistically significant changes in BBB tightness and EC junctional genes expression caused by the exposure to flow (n = 4; p < 0.05).
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monooxygenase engaged in the metabolic transforma-
tion of fatty acids and the synthesis of cholesterol;
CYP11B1 is a steroid 11b-hydroxylase involved in the
biosynthesis of steroids. Additional CYP RNA levels that
were significantly upregulated are that of CYP19A1 (bio-
synthesis of estrogens) and that of CYP27A1. The latter
is a mitochondrial P-450 enzyme with broad substrate
specificity for C27 sterols (e.g., cholesterol degradation).
Exposure to flow promotes the endothelial expression of
ion channels and specialized transport systems
Our results (see Figure 3A) showed that exposure to flow
increased the RNA levels of different classes of ion chan-
nels. These included voltage-gated potassium channels
(e.g., KCNCB1, KCNCB2, KCNQ1, KCNQ2, and
KCNQ3), voltage-dependent calcium channels (e.g. CAC-
NA1D, CACNB1, CACNB2, and CACNB3) inwardly rec-
tifying potassium channel (e.g., KCNJ15) delayed-rectifier
potassium channels (e.g., KCNS1) and other voltage-
dependent anion channel (VDAC1, 2, and 3).
Among the many roles played by the BBB that of sup-
plying essential nutrients to the CNS and regulating
ionic trafficking and fluid movements between the blood
and the brain are considered among the most crucial
functions. The BBB has a very low permeability to ions
and polar molecules thus, the presence of specific trans-
porters is essential to regulate the trafficking of these
substances across the vascular endothelium. Our results
(see Figure 3B) showed that the RNA level of a number
of crucial endothelial transporters was significantly
altered by the exposure to physiological capillary levels
of SS. RNA level of members of the “facilitate glucose
transporters family” such as Glut-1 (SLC2A1), Glut-2
(SLC2A2), Glut-3 (SLC2A3) and Glut-5 (SLC2A5) were
significantly increased. That of Acetyl-CoA transporter
(SLC33A1) was also significantly upregulated (>250% in
comparison to static culture conditions). Similar trend
was observed for the RNA level of organic anions and
cations transporters (SLCO2A1 and SLC22A1) as well
as that of cationic aminoacids (SLC7A2), folate
(SLC19A1), sulfate (SLC26A2), mitocondrial carriers
(SLC25A1 and SLC25A4). Several ions transporters
(SLC12A2. SLC12A4) were also upregulated (> 200% in
comparison to static condition). By contrast, the RNA
level of sodium/hydrogen exchanger (SLC9A3R1), the
copper transporter (SLC31A1), and that of a mitochon-
drial phosphate carrier (SLC25A3) were decreased. All
the results were statistically significant (n = 4; P < 0.05).
Shear stress facilitates endothelial-leukocyte cross-talk to
respond to pro-inflammatory stimuli
The recruitment of leukocytes from the blood stream
and their subsequent interaction (rolling, adhesion and
locomotion) with the vascular endothelium are critical
stages of the immune response during inflammation.
The detail mechanisms controlling leukocyte-endothelial
interaction at the BBB as well as the molecular media-
tors that are involved in the process are not fully under-
stood. It is clear however, that the vascular endothelium
plays a crucial role in this process through the presenta-
tion of various adhesion ligands at sites of inflammation.
Our study (see Figure 4A) has shown that exposure to
SS increased the RNA levels of several key adhesion
molecules including ICAM1, VCAM1 and PECAM1,
which play an important role on the adhesion and
migration of T lymphocytes [5,13]. E and P-selectin
RNA was instead downregulated. Some data suggest
that they do not have a critical role in leukocyte
Figure 2 Shear stress enables vascular-dependent shielding of
brain from unwanted and potentially harmful substances. Shear
stress increases the RNA levels of gene encoding for multidrug
resistance proteins (panel A) and cytochrome P450 enzymes (panel
B). Note that “*” refers to a statistically significant (n = 4; p < 0.05)
increase of the genes transcription in EC exposed to flow versus
those grown under static conditions.
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not fully understood. Integrins play a role in cell signal-
ing and therefore they are involved with the interactions
between ECs and the surrounding environment. Expo-
sure to SS increases the RNA level of several integrins
(see Figure 4B). For example the alpha chains 2, 3, 7
(ITGA2, ITGA3, ITGA7) and the beta chains 1, 5, and 8
(ITGB1, ITGB5, and ITGB8) interact with the extracel-
lular matrix (ECM) [15].
Shear stress modulate the bioenergetic behaviour on the
BBB endothelial cells
Our results (see Figure 5A) have shown that the ECs
RNA level of the key metabolic switch controller
Figure 3 Shear stress enhances the RNA levels of ion channel genes and other relevant transporters. Note that “*” refers to a statistically
significant (n = 4; p < 0.05) increase of the genes transcription in EC exposed to flow versus those grown under static conditions. Note also that
the data in panel B are reported as % of the RNA level measured in EC grown under static condition ± SEM.
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is significantly increased by the exposure to flow. By
contrast that of lactate dehydrogenase (aerobic to anae-
robic pathway) is decreased. In addition to that, the
RNA level of many dehydrogenases and other key
enzyme controlling the Krebb cycle (aerobic respiration)
including the Acetyl-coA transporter (see Figure 5B)
were also increased. The effect of flow on the glucose
metabolism was confirmed by measurements of glucose
consumption and lactate production over a period of 3
weeks from the establishment of the co-culture systems
(see Figure 5C). Our experimental data showed that
endothelial cells grown under dynamic conditions
develop a metabolic behavior that makes significant use
of aerobic respiration. This is demonstrated by the com-
parative measurements of lactate produced over glucose
consumed (ratio ≈ 1 )s h o w i n gt h a ta tl e a s t5 0 %o ft h e
glucose is channeled into the citric acid cycle and meta-
bolically converted in CO2 and H2O with a significant
release of bioenergetic equivalents (ATP; NADH, etc.).
This was not observed in parallel co-cultures where ECs
were not exposed to flow. In this case we measured a
lactate produced over glucose consumed ratio ≈ 2. In
this case each molecule of glucose underwent anaerobic
metabolic transformation into two molecules of lactate.
These data further strengthen previous funding [16]
suggesting that the exposure to intraluminal flow plays a
key role in determining the intracellular bioenergetic
pathway (aerobic or anaerobic). This hypothesis is also
supported by the fact that the corresponding expression
levels of the key enzymes controlling the aerobic meta-
bolic pattern were also upregulated (see Figure 5D). By
contrast, the expression of lactate dehydrogenase,
(which converts pyruvate into lactate thus, ending the
glycolytic energy biotransformation of glucose) was
downregulated.
Laminar shear stress inhibits endothelial cell proliferation
Inhibition of cell proliferation is a common prodromic
event to cell differentiation. Our results showed that SS
affects the transcription of genes involved in the cell
cycle regulation. BTG proteins are in this specific case
novel regulators of transcription engaged in the control
of the cell cycle. Although the biological array of func-
tions of BTG proteins is not fully understood, it is
known that BTG1 act as a growth arrest gene responsi-
ble for the maintenance of the quiescent state, while
BTG2 acts as a negative regulator of the cell cycle.
Therefore both BTG1 and 2 act as negative regulators
of cell proliferation (see Figure 6A). Our results have
shown that SS significantly increases the RNA level of
both B-cell translocation gene 1 (BTG1) and gene 2
(BTG2) (see Figure 6B). BTG1 and 2 also interact with
protein arginine N-methyltransferase 1 (PRMT1) [17],
which activity is critical for growth factor-induced cell
differentiation [18]. By contrast, the RNA level of key
regulators G1/S checkpoint phase which favor cell divi-
sion such as CDK4/6-cyclin D, Cyclin D1, the transcrip-
tion factor E2F1 as well as that of histone deacetylase 1
(HDAC1) [19,20] was significantly decreased. Gene
array data were also supported by parallel analysis and
comparative quantification of the corresponding pro-
teins (see Figure 6C). Our data have shown that SS sig-
nificantly increased the expression of PRMT1 (3.07 ±
SEM 0.184) as well as that of cyclin-dependent kinase
inhibitor (p27, Kip1) (2.54 ± SEM 0.209). By contrast,
retinoblastoma binding protein and E2F transcription
factor 1 were significantly downregulated (-2.52 ± SEM
0.168 and 2.22 ± SEM 0.279 respectively).
These results were also indirectly corroborated by
measurement of the sub-cellular (nucleus, cytoplasm,
Figure 4 Shear stress enables endothelial-leukocyte interaction.
Shear stress increased the transcription level of relevant adhesion
molecules (Panel A) and integrins (Panel B) thus facilitating the
cross-talk between the vascular endothelium and the host immune
system at the BBB level. Note that “*” and “**” refers to a statistically
significant (n = 4; p < 0.05) changes (increase and decrease
respectively) of adhesion molecules and integrins genes
transcription in EC exposed to flow versus those grown under static
conditions.
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Page 6 of 15Figure 5 Shear stress modulates the endothelial bioenergetic pathway. Panel A and B Enzimatic pathways of glycolysis and Krebb’s cycle.
Note the change in the expression of genes encoding for the key regulator enzymes of glucose metabolism and how the exposure to flow
greatly favoured the more efficient aerobic pathway. The gene array data were confirmed by measurements of glucose consumption versus
lactate production in DIV-BBB model developed with and without l endothelial exposure to intraluminal flow (Panel C). Comparative analysis of
the expression level of key enzymes regulating the glycolitic and the aerobic (Krebb’s cycle) pathways strongly supported the gene array data
(Panel D). Note that the lactate production/glucose consumption ratio measured in the flow-exposed in vitro BBB modules was ≈ 1. Complete
anaerobic metabolism would produce 2 lactates/glucose (ratio = 2) thus, indicating that at least 50% of the glucose consumed underwent
aerobic metabolism.
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Page 7 of 15Figure 6 Shear stress inhibits cell proliferation.P a n e lA: schematic representation of the cell cycle regulation by BTG family proteins.
Functional correlation between gene expression and cell cycle was determined using Pathway analysis software. Note how shear stress
increased the RNA levels of genes encoding the cell cycle inhibitory effectors BTG1, BTG2 and PMRT1 (Panel B). This finding was also supported
by the comparative analysis (flow vs. no-flow) of the expression level of cell cycle modulatory proteins (Panel C). Note that genes and protein
related to positive modulators of the cell cycle progression were significantly downregulated. Note also that “*” and “**” refers to a statistically
significant (n = 4; p < 0.05) changes (increase and decrease respectively).
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(see Figure 7). Our results showed that the exposure to
flow significantly increased the expression of cytoskeletal
proteins (see Figure 7A) while reducing that of the other
sub-cellular fractions. The total amount of protein con-
tent/cell was increased by flow and the sub-cellular pro-
t e i nc o n t e n ts h o w e dt h a tt h el a r g e s tc o m p o n e n to ft h e
total cellular protein pool (86.79%) was made by cytos-
keletal proteins (see Figure 7B) with cytosolic, nuclear
and membrane protein pools significantly reduced
(20.48 to 3.03%; 17.38 to 8.58%; and 3.77 to 1.6%
respectively).
Discussion
BBB endothelial cells in vivo are continuously exposed
to laminar shear stress to which they respond by struc-
tural (cell orientation with flow direction; redistribution
of cell fibers and flattening) and functional remodeling
showing significant evidences of differentiation [21-24].
One of the main functions of the BBB is shielding of
the brain from unwanted and potentially harmful sub-
stances. Tight junction protein complexes provide a
mechanical means to seal the paracellular pathways
between adjacent endothelial cells [8,24]. Our study
shows that exposure to flow increases the RNA levels of
genes encoding for a variety of tight junctional proteins
(see Figure 1A) including the intracellular scaffold pro-
teins Zonula occludens-1 (ZO1) and 2 (ZO-2) which
link the junctional molecules claudin and occludin to
intracellular actin and the cytoskeleton. Claudin 3, 5
and actin gene espression were also upregulated by the
exposure to laminar shear stress thus strongly suggest-
ing that acting as a key regulator of TJ expression. In
addition to TJ protein upregulation we also found a sig-
nificant increase the RNA and protein levels of several
c a d h e r i n s .T h e s ea r eac l a s sof type-1 transmembrane
proteins which play important roles in cell adhesion,
through the formation of adherens junctions. Our data
showed the up-regulation of N-, P- and VE-cadherin.
We also observed an increase in the RNA and protein
levels of E-cadherin. However, even though the upregu-
lation of E-cadherin (commonly though not exclusively
expressed in epithelial cells [25,26]) was statistically sig-
nificant; its overall RNA and total protein expression
levels were very modest in comparison to that of the
other adherens junction components.
The result is the formation of tight barrier with high
trans-endothelial electrical resistance that can efficiently
discriminate the passage of substances according to their
permeability coefficient. In the absence of intraluminal
flow despite the presence of abluminal astrocytes the
resulting barrier is much less stringent and does not pro-
vide selective permeability (Figure 1D). This demonstrates
that glial stimuli are important but not sufficient to estab-
lish a functional BBB and that exposure to flow provides
the missing modulatory element to enable BBB properties.
BBB shielding function however, is also achieved at
other levels: 1) by mechanisms of drugs extrusion. This
is carried out by ATP-binding cassette transporters
(ABC transporters) which are transmembrane proteins
that utilize the energy of adenosine triphosphate (ATP)
hydrolysis to translocate a broad range of substrates
across the cellular membranes [27-29]; 2) by enzymatic
metabolism of substances that enter the cell. This func-
tion performed is by cytochrome P450 enzymes similar
to those present in the hepatocytes. These enzymes can
use a variety of molecules (including exogenous sub-
stances such as drugs and potentially toxic chemicals) as
substrates in enzymatic reactions [3,12].
Our study shows that exposure to flow increases gene
expression of several efflux transporters including the
Figure 7 Shear stress increases cytoskeleton protein
expression while decreasing that of cytosol, nucleus and
membrane. Note the drastic changes related to cytoskeletal protein
expression. In EC grown under flow condition cytoskeletal proteins
represent account for majority of the total protein content. Note
also that the exposure to flow significantly decreased the overall
expression of nuclear, cytosolic and membrane proteins. This is
consistent with endothelial morphologic adaptation to flow and
with a reduced cell proliferation. Note that “*” and “**” refers to a
statistically significant (n = 4; P < 0.05) changes (increase and
decrease respectively) in the protein content.
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and members of the multidrug resistance associated
protein family MRP1 (ABCC1), MRP2 (ABCC2), and
MRP5 (ABCC5) (see Figure 2A). P-glycoprotein (P-gp)
the products of the MDR1 gene is an effluxer with spe-
cificity for cationic or electrically neutral substrates as
well as a broad spectrum of amphiphilic substrates [30]
while MRPs are multispecific organic anion efflux trans-
porters. Togheter these efflux transporters can drasti-
cally reduce brain penetration of a broad range of
endogenous and exogenous substances which do not
follow a paracellular pathway to cross the vascular
endothelium.
The “third” barrier is instead metabolic in nature. The
BBB endothelium is also provided with cytochrome
P450 enzymes which catalyze the oxidation of organic
substrates such as lipids and steroidal hormones but
also exogenous substances including drugs [3].
Recent studies [11] have shown that BBB endothelial
p450 enzymes may be co-responsible for the onset of
drug resistance to pharmacological treatments. For
example, carbamazepine (CBZ) is an anticonvulsant cur-
rently used in the pharmacological treatment of epileptic
patients. CBZ is a P450 CYP3A4 substrate. Overexpres-
sion of CYP3A4 has been shown to correlate with that
of MDR1 at the blood-brain barrier interface of patients
with drug refractory epilepsy. Our study has shown that
exposure to flow significantly increases gene expression
levels of most members of the cytochrome P450 families
CYP1 (including CYP3A4), CYP2, and CYP3. Taken
togheter the increased gene expression of multidrug
resistance proteins and P450 enzymes provides a com-
plex mechanism to regulate the CNS drug bioavailabil-
ity, or to shield the CNS.
The RNA level of CYP11B1, and CYP19A1 were also
upregulated by flow. These enzymes are involved in
the biosynthesis of steroids and estrogen, which modu-
late many biological activities including BBB perme-
ability and leukocytes adhesion [31,32]. CYP27A1 RNA
level was also significantly upregulated by flow. These
P450 enzymes are responsible for the degradation of
cholesterol and play an in important role in the main-
tenance of cholesterol pool in the CNS [33,34]. This is
in agreement with the fact that enhancement of
endothelial permeability and lipid deposition preferen-
tially occurs at turbulent, low shear stress regions such
as in the arteries [35].
The shielding provided by the BBB may on the other
end limit the paracellular diffusion of polar substances
including ions and essential nutrients (e.g.,glucose and
amino acids) necessary for the maintenance of neuronal
activity. Therefore the BBB endothelium must be
equipped with specific transporters to supply the CNS
with these substances without compromising its barrier
functions and its ability to maintain the homeostasis of
the brain environment. Our data have shown that the
exposure to SS positively modulates the translational
expression of Ca
2+ and K
+ ion channels. Calcium and
potassium homeostasis play an important role in the
control of neuronal excitability but are also involved in
macrophage transmigration across the vascular endothe-
l i u ma tt h eB B B[ 3 6 ] .F u r t h e r m o r e ,C a
2+ is involved in
the modulation of BBB integrity and endothelial mor-
phology [37,38].
In addition to ion channels the gene expression level
of other specialized solute carriers was also found to be
modulated by flow. These include members of the glu-
cose transporters family Glut-1, Glut-2, Glut-3 and
Glut-5 [39,40]; solute carriers specific for cationic ami-
noacids, organic anions and cations, folate, sulfate as
well as the Na-K-Cl symporter and the potassium-chlor-
ide cotransporter. All together these specialized func-
tions represent the hallmark of a drastic differentiation
process that set the brain microcapillary endothelium
aside from those forming other vascular beds.
Transporters allow nutrients and other biologically
important substances to transit from the blood into the
brain across the BBB. To efficiently meet the bioener-
getic demand of the many active transport systems that
are critical for sustaining neuronal function the BBB
E C sm a k eas u b s t a n t i a lu s eo fa e r o b i cr e s p i r a t i o no r
Citric acid cycle. This is an oxigen-dependent 8-step
enzimatic process that allows the full conversion of 2
molecules of acetyl-CoA (derived from the conversion
of glucose during glycolysis) into carbon dioxide (CO2)
and water (H2O). The theoretical energetic yield of the
process from the complete oxidation of one glucose
molecule to CO2 and H2Oi so f6N A D H ,2F A D H 2,
and 2 ATP (equivalent to 36 ATP molecules). The aero-
bic pathway also provides reductant equivalents (such as
NADH) to counteract the harmful effect of reactive oxi-
dative species generated intracellularly or originating by
exposure to xenobiotic substances.
Our results show that exposure to flow plays a critical
role in the modulation of the BBB-Ec bioenergitic meta-
bolism favoring the expression of genes encoding for
the key enzymes operating the conversion of acetyl-CoA
into CO2 and H2O during the citric acid cycle. Further-
more, shear stress increases the RNA levels of pyruvate
dehydrogenase (which converts pyruvate into acetyl-
CoA; that of the mitocondrial acetyl-CoA transporter
and downregulates the expression level of lactate dehy-
drogenase which converts pyruvate into lactate (see Fig-
u r e5 A ,Ba n d5 D ) .T h ea e r o b i cm e t a b o l i ci n d u c t i o n
operated by flow on the BBB endothelium was further
confirmed by lactate production and glucose consump-
tion measurements demonstrating that at least 50% of
the glucose was processed by aerobic respiration.
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tion by flow” is that BBB endothelial cells can adapt
their metabolic process according to the availability of
oxygen. This is dependent on blood flow therefore, It is
logic to postulate that whether blood flow is interrupted
(e.g., ischemia or stroke) or the oxygen content in the
blood is reduced (venules), the vascular endothelium
can switch to an anaerobic respiration to meet its ener-
getic demand.
Controls on cell proliferation and differentiation are
interrelated even though it is still not clear to what
extent. Our data (see Figure 6) show that exposure to
flow increases the RNA levels of BTG proteins (BTG1
and 2) which are negative regulators of the cell cycle
[41]. BTG1 or BTG2 bound to PRMT 1 (which RNA
and protein expression levels were also increased by
flow; see Figure 6B and 6C) is required to induce
growth inhibition [17]. Furthermore, the RNA level of
cyclin D, cdk4, and 6, which control the re-entry of rest-
ing G0 cells into the G1 phase of cell cycle were down-
regulated. Cells that exit the cell cycle to enter and stay
at resting (G0) phase is characteristic of terminally dif-
ferentiated cells. Quantitative analysis of the protein
content (see Figure 7) relative to nucleus, cytosol, cytos-
keleton, and membrane sub-cellular fractions have
shown a drastic reduction of the nuclear protein content
in EC exposed to flow. This is in agreement with the
lack of DNA synthesis in resting cells and the fact that
in vivo the endothelial DNA synthesis preferentially
occurs at branch orifices characterized by low and tur-
bulent flow [42]. Furthermore, we observed a substantial
increase in cytoskeletal protein content. This can be
related to a morphological adaptation of the BBB
endothelium to flow and the necessity to provide struc-
tural support for TJ protein complexes [24].
Taken togheter our results suggest that the exposure
to a capillary level laminar shear stress on one hand
favors EC differentiation into a BBB phenotype and on
the other hand inhibits the cell cycle. However, whether
the two processes are simultaneously regulated is still
unclear.
Conclusion
Shear stress plays a key role in modulating endothelial
structure and function. Our study shows that SS-depen-
dent effects on EC are modulated by induction/suppres-
sion of genes regulating multiple aspects of endothelial
physiology; from the formation of inter-endothelial tight
junction to the expression of specific carrier-mediated
transporters and drug resistance mechanisms. Studies by
other have also shown that SS induces the production
of vasoactive substances [43]. Turbulent, but not lami-
nar shear stress stimulates EC turnover [44]. Accord-
ingly, in vivo DNA synthesis of EC preferentially occurs
at branch orifices with low flow rates [45,46] which is
paralleled by the enhancement of endothelial permeabil-
ity [47]. Genomic and proteomic analyses are currently
being used to study the BBB and how it relates to the
pathogenesis of major neurological diseases [48]. In this
respect this study provides the bases for new hypotheses
and future studies to unveil novel unexploited clinical
targets that can facilitate the development of innovative
therapeutic strategies to reduce the burden of BBB-
related CNS diseases.
Methods
Cell Culture
Normal human brain microvascular endothelial cells
(HBMEC, cat# 1000, ScienCell Research Laboratories,
San Diego, CA 92121) and human astrocytes (HA, cat#
1800) were initially expanded in 75 cm
2 flasks pre-
coated with fibronectin (3 μg/cm
2) and Poly-d-Lysine (3
μg/cm
2) respectively. Endothelial growth medium con-
sisting of MCDB 105 (Sigma, Cat# M6395), 10% human
AB serum (SIGMA, Cat# S-7148), 15 mg/100 ml of
endothelial cell growth supplement (ECGS, Cat.# 1052),
800 units/ml of heparin (Sigma, cat# H3393), 100 units/
ml penicillin G sodium and 100 mcg/ml streptomycin
sulfate was used to expand HBMEC cultures. HA were
expanded in Dulbecco’s modified essential medium
(DMEM-F12) supplemented with 2 mM glutamine, 5%
fetal bovine serum (FBS), 100 units of penicillin G
sodium per ml, and 100 μg of streptomycin sulfate per
ml. HBMEC and HA were maintained at 37°C in a
humidified atmosphere with 5% CO2. Cellular growth
was monitored every day by inspection with phase con-
trast microscopy. To minimize the dedifferentiation pro-
cess cell cultures were not expanded for more than two
cycles. Prior to use at the end of the expansion process
HBMEC were characterized by immunocytochemistry
using sheep polyclonal antibodies that recognized the
human Von Willebrand Factor Antigen VIII (vWF/Fac-
tor VIII, US biological, Swampscott, MA, cat# F0016-
13A) and were found to be > 99% pure endothelial cells
[49]
DIV-BBB setup
HBMEC and HA were cultured in the DIV-BBB, as pre-
viously described [50,51]. Briefly, HBMEC are first
inoculated into the luminal compartment and allowed
to adhere under static conditions over a 48-hr period. In
order to achieve higher levels of cell attachment, the
flow path was canalized through the extra-capillary
space. Endothelial cells were then exposed to a low-level
shear stress (1 dyne/cm
2) for 24 hours. The shear stress
was then raised to a constant value of 4 dyne/cm
2 over
the course of the following week and then brought to
final (capillary-like) level of 6.2 dyne/cm
2[6,7]. Please
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erate within the DIV-BBB system shear stress levels ran-
ging from 0.8 up to 42 dyne/cm
2. Astrocytes were
seeded on the abluminal surface of the fibers three days
after the initial loading of the endothelial cells. Typically
two weeks of co-culture are required to establish a fully
functional BBB with a TEER greater than 600 Ω cm
2
above the baseline (empty module).
To maintain similar culture conditions without expos-
ing the endothelial cell (EC) to flow, parallel DIV-BBB
modules were established with the following procedure.
Astrocytes were first seeded in the abluminal space and
left adhere for 48 hours while maintaining a luminal
medium flow. Then the flow path was canalized through
the extra-capillary space and the endothelial cells were
seeded intraluminally. Flow was then maintained extra-
luminally for the duration of the experiment.
At the end of the experiment EC were harvested and
processed for RNA purification and protein extraction
from the cytosol, membranes, nucleus, and cytoskeleton
using Qproteome Cell Compartment Kit (Quiagen,
Valencia, CA cat# 37502) according to the protocol pro-
vided by the manufacturer.
TEER measurement
BBB formation was monitored by real time measure-
ments of trans-endothelial electrical resistance (TEER;
Flocel Inc., Cleveland OH). The device interfaces directly
to a PC computer via Universal Serial Bus (USB) and uti-
lizes electronic multiplexing to assess the integrity and
viability of tissue culture bilayers. The microcontroller
computes the resistivity and capacitance per cm
2 of the
barrier from physical parameters. TEER was measured
continuously from the initial setup throughout the course
of each experiment. Previous work in our laboratory [16]
showed a direct (inverse) relationship between TEER and
BBB permeability in the DIV-BBB.
Glucose consumption and lactate production
Medium samples were simultaneously collected every
few days from the luminal and abluminal compartments
of each DIV module. The concentration of glucose and
lactate was determined via a dual channel immobilized
oxidase enzyme analyzer (YSI 2700 SELECT, YSI Inc.,
Yellow Springs, OH). Samples were kept frozen after
being collected and processed at a later time, when mul-
tiple samples from the same experiment could be run
simultaneously. The enzyme analyzer was set to recali-
brate itself six samples as multiple samples were ana-
lyzed in the same run.
RNA Extraction
Endothelial cells were purged from the DIV modules by
gentle enzymatic dissociation using trypsin and 2 mg/ml
collagenase and collected by centrifugation. Note that
EC were compartmentally isolated from the abluminal
astrocytes by the hollow fibers wall which is not permis-
sive for intercompartimental cell migration across. EC
from suspension were pelleted by centrifugation at 1,000
× g. Supernatant media was removed without washing
and cells were incubated in TRIZOL Reagent (1 ml/5-10
×10
6 cells) for 5 minutes at 30°C to permit the complete
dissociation of nucleoprotein complexes. Next, 0.2 ml of
chloroform/ml of TRIZOL were added. Sample tubes
were capped and shaken vigorously 15 seconds and left
to incubated at 30°C for 2 to 3 minutes. Samples were
then centrifuged at 12,000 ×g for 15 minutes at 8°C.
Following centrifugation, the mixture separated into a
lower red, phenol-chloroform phase, an interphase, and
a colorless upper aqueous phase containing the RNA.
RNA precipitation
RNA from the aqueous phase was precipitated by mix-
ing with 0.5 ml of isopropyl alcohol/1 ml of TRIZOL
and left to incubate for 10 minutes at 30°C following by
centrifugation at 12,000 ×g for 10 minutes at 8°C. The
supernatant layer was then removed and the RNA pellet
was washed, once with 75% ethanol (1 ml/1 ml of TRI-
ZOL used for the initial homogenization). The samples
were mixed by vortexing and centrifuged at 7,500 ×g for
5 minutes at 8°C. The RNA pellet was then dissolved in
RNase-free water.
RNA purification and gene analysis
RNA samples were run through Qiagen RNeasy col-
umns (Qiagen USA, Valencia, CA) to remove any geno-
mic DNA contamination. The purity of RNA was
determined by measuring the absorbance of the sample
diluted in a solution of 10 mM Tris Cl, pH 7.5 buffer at
the wavelengths of 260 nm and 280 nm and calculating
a ratio of these absorbance values. Pure RNA has an
A260/A280 ratio of >1.90. Samples were then processed
by Illumina bead-array based gene expression platform
at Genomics Core Facility using HumanRefSeq8 Bead-
Chips. Each of these microarrays on the Human-8 Chip
contains 23,000 oligonucleotide probes (corresponding
to over 23,000 well-characterized genes). Transcription
changes were analyzed with Ingenuity Pathway Analysis
(IPA
® 8.7) software (Ingenuity™Systems, Redwood City,
CA). This application allows analyzing targeted informa-
tion on genes, proteins, chemicals, and drugs, and build-
ing interactive models of the experimental systems (Path
Designer).
Note that genes were considered expressed in the spe-
cific population and included in the analysis only if they
were flagged as present in all 4 replicates/experimental
condition by the gene chip operating software, if average
normalized signal intensity minus background value was
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protocol), and p values were <0.05.
Endothelial cells protein separation
Protein extraction from the cytosol, membranes, nucleus,
and cytoskeleton was performed by using Qproteome
Cell Compartment Kit (Quiagen, Valencia, CA cat#
37502) according to the manufacturer protocol for sub-
cellular extraction of proteins. The stepwise extraction
delivers four distinct protein fractions from one sample:
Cytosolic, membrane/organelle protein, nucleic and
cytoskeletal. Proteins are obtained in the native state and
readily usable for 2D gel electrophoresis.
2D gel electrophoresis
2-D electrophoresis is commonly used to analyze a large
number of proteins/sample which can be detected, ana-
lyzed and quantified by different means. The proteins
isolated as described above were then precipitated with
acetone and reconstituted in an isoelectric focusing buf-
fer consisting of 6M urea, 2M thiourea, 2% of 3-(3-
chloramidopropyl)dimethylammonio-1-propane sulfate
(Chaps), 1% Triton X100, 1% ampholytes and 50 mM
dithiothreitol (DTT). Isoelectric focusing was carried out
for 43 kVh at 20°C in 11-cm immobilized pH gradient
strips (BioRad, Hercules - CA) covering pI 5 to 8, which
were loaded with 500 μg total protein using the active
rehydration method. The second dimension was carried
out in precast 12% SDS-Page gels (Criterion gels,
BioRad). Gels were subsequently fixed and stained with
Coomassie blue (GelCode Blue, Pierce, Rockford - IL).
2D gel analysis
Relative expression of the recovered proteins (flow ver-
sus no flow) was determined by densitometric analysis.
Two-dimensional protein gels were scanned using a 35-
mm camera mounted on a gel scanning unit interfaced
to a PC using GelPro™ analysis software. The scanned
grayscale images were saved in an uncompressed TIFF
format and further analyzed using software specifically
designed for measuring grayscale image density, devel-
oped by Nonlinear USA, Inc. (Durham, NC) Phore-
tixTM ID (Version 2003.01).
Statistical analysis
For parametric variables (e.g., TEER levels, glucose con-
sumption, lactate production, cytokines, and gene expres-
sion levels), differences between populations were
analyzed by ANOVA. p values <0.05 were considered sta-
tistically significant. Bonferroni analysis was used to
account for comparisons of multiple parameters among
groups. For non-parametric indices (e.g. densitometries
for 2D gel electrophoresis), we used Kruskal-Wallis test
followed by Mann-Whitney U-test. Endothelial cells
isolated from a group of 4 independent DIV-BBB modules
per experimental condition were used for the gene analy-
sis, thus the reported gene expression levels are an average
of 4 independent arrays. Based upon previous experi-
ments, the number of independent gene arrays replicates
analyzed for each experimental condition provides suffi-
cient power to demonstrate statistical significance.
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